Head to Head Review: EMS-CHEMIE (OTCMKTS:EMSHF) vs. International Flavors & Fragrances (NYSE:IFF)

EMS-CHEMIE (OTCMKTS:EMSHF) and International Flavors & Fragrances (NYSE:IFF) are both materials companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, institutional ownership, dividends, risk, earnings, analyst recommendations and profitability.

Profitability

This table compares EMS-CHEMIE and International Flavors & Fragrances’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
EMS-CHEMIE	N/A	N/A	N/A
International Flavors & Fragrances	7.78%	7.65%	4.25%

Insider and Institutional Ownership

6.6% of EMS-CHEMIE shares are held by institutional investors. Comparatively, 96.0% of International Flavors & Fragrances shares are held by institutional investors. 1.1% of International Flavors & Fragrances shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of recent ratings for EMS-CHEMIE and International Flavors & Fragrances, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
EMS-CHEMIE	0	1	1	0	2.50
International Flavors & Fragrances	0	5	13	0	2.72

International Flavors & Fragrances has a consensus target price of $91.16, indicating a potential upside of 12.62%. Given International Flavors & Fragrances’ stronger consensus rating and higher probable upside, analysts clearly believe International Flavors & Fragrances is more favorable than EMS-CHEMIE.

Earnings & Valuation

This table compares EMS-CHEMIE and International Flavors & Fragrances”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
EMS-CHEMIE	N/A	N/A	N/A	N/A	N/A
International Flavors & Fragrances	$10.89 billion	1.90	-$361.00 million	$3.27	24.76

EMS-CHEMIE has higher earnings, but lower revenue than International Flavors & Fragrances.

Summary

International Flavors & Fragrances beats EMS-CHEMIE on 9 of the 9 factors compared between the two stocks.

About EMS-CHEMIE

EMS-CHEMIE HOLDING AG engages in the high performance polymers and specialty chemicals businesses in the United States, Europe, Asia, and internationally. The company's High Performance Polymers segment is involved in the manufacture and supply of high-performance polyamide granulate. Its Specialty Chemicals segment develops, produces, and sells fibers, fusible adhesives, and adhesive yarns for technical and textile applications, powder coatings, and reactive diluents. The company also offers bonding, coating, sealing, and damping systems; and hotmelt adhesives, crosslinkers, epoxy systems, technical fibers, adhesion promoters, and fusible bonding yarns and granules. It serves automotive, electro and electronic, industry and consumer goods, optic, and packaging markets. The company was founded in 1936 and is based in Domat/Ems, Switzerland. EMS-CHEMIE HOLDING AG is a subsidiary of EMESTA HOLDING AG.

About International Flavors & Fragrances

International Flavors & Fragrances, Inc. engages in the manufacture and supply of flavors and fragrances used in the food, beverage, personal care, and household products industries. It operates through the following segments: Nourish, Health & Biosciences, Scent and Pharma Solutions. The Nourish segment consists of legacy Taste segment combined with N&B’s Food & Beverage division and the food protection business of N&B’s Health & Biosciences division. The Health & Biosciences business consists of a biotechnology-driven portfolio of enzymes, food cultures, probiotics and specialty ingredients for food, home and personal care, and health and wellness applications. The Scent business creates fragrance compounds, fragrance ingredients and cosmetic ingredients that are integral elements in the world’s finest perfumes and best-known household and personal care products. The Pharma Solutions business produces a vast portfolio including cellulosics and seaweed-based pharma excipients, used to improve the functionality and delivery of active pharmaceutical ingredients, including controlled or modified drug release formulations, and enabling. The company was founded in 1833 and is headquartered in New York, NY.